Floatz logo

Chromium Picolinate

Atypical Depression

Pennington Biomedical Research CenterN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Atypical Depression cohort.

Asset / SponsorPhaseRating
Duloxetine
New York State Psychiatric Institute
Phase 4BB
Cipralex
Duke University
Phase 3BB

Same molecule, other indications

Chromium Picolinate is also rated in:

obesity disorderDormant
CC
Indicative ·
46 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
D
Indicative ·
30 / 100
View asset →
type 2 diabetes mellitusDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →